On Tuesday, Pfizer Inc. (NYSE:PFE) released its full-year 2025 financial guidance, projecting revenues between $61.0 billion and $64.0 billion compared to a consensus of $63.28 billion. For 2025, Pfizer expects revenue from COVID-19 products to remain consistent with 2024, excluding approximately $1.2 billion in one-time Paxlovid revenue recognized in 2024. The guidance accounts for an estimated $1 billion net unfavorable revenue impact due to c…

Benzinga

New York

United States

Why Is Pfizer Stock Trading Higher On Tuesday? - Pfizer (NYSE:PFE)

Pfizer on Tuesday forecast 2025 profits roughly in line with Wall Street expectations, offering some relief to investors after a tumultuous year.

Ad Fontes Media

All Sides

Media Bias/Fact Check

CNBC

Roberts family

Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

BizToc

Pfizer Sees 2025 Revenue in Line With Wall Street Views

Upstract

Pfizer (NYSE:PFE) Trading Down 0.4% Following Analyst Downgrade

marketbeat.com

Pfizer (NYSE:PFE)  Shares Down 0.4%  Following Analyst Downgrade

CHARLESTON, W.Va. — West Virginia Attorney General Patrick Morrisey on Thursday said the Circuit Court of Mason County has approved a settlement between the state and pharmaceutical companies Pfizer Inc. (and related companies) and Ranbaxy Inc. (and related companies) in…

Beckley Register-Herald

Multimillion-dollar settlement with Pfizer, Ranbaxy on Lipitor Antitrust Lawsuit announced

The company expects sales and earnings to meet analysts' forecasts, but it still faces questions about its pipeline.

STAT

The Boston Globe

Boston

Suffolk County

Massachusetts

Pfizer’s 2025 forecast meets expectations and leaves room for debate

Pfizer forecasts 2025 profits that align closely with market expectations, providing a degree of reassurance for investors amid prior criticisms. The company anticipates adjusted earnings per share between $2.80 and $3, while revenue estimates range from $61 billion to $64 billion. Pfizer predicts 2025 profits in line with market expectations Despite the affirmations, Pfizer’s guidance for 2025 sales marginally missed analyst forecasts, which es…

Dataconomy

Pfizer’s 2025 forecast falls short but investors find a silver lining

Pfizer (NYSE:PFE – Get Free Report) updated its FY25 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.80-3.00 for the period, compared to the consensus estimate of $2.86. The company issued revenue guidance of $61-64 billion, compared to the consensus revenue estimate of $63.22 billion. Pfizer also updated its FY […]

watchlistnews.com

Pfizer (NYSE:PFE) Issues FY25 Earnings Guidance

Pfizer Inc. (NYSE:PFE – Get Free Report)’s stock price fell 0.4% during trading on Wednesday after Truist Financial lowered their price target on the stock from $36.00 to $32.00. Truist Financial currently has a buy rating on the stock. Pfizer traded as low as $26.12 and last traded at $26.32. 8,655,838 shares were traded during […]

Why Is Pfizer Stock Trading Higher On Tuesday? - Pfizer (NYSE:PFE)

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics